Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37594060)

  • 1. [Risk factors for cancer-related cognitive impairment in breast and colorectal cancer patients who undergo chemotherapy].
    Iranzo P; Callejo A; Arbej J; Menao S; Isla D; Andrés R
    An Sist Sanit Navar; 2023 Aug; 46(2):. PubMed ID: 37594060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients.
    Chae JW; Ng T; Yeo HL; Shwe M; Gan YX; Ho HK; Chan A
    PLoS One; 2016; 11(10):e0164204. PubMed ID: 27701469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate-term cognitive impairment following intravenous (IV) chemotherapy: a prospective pre-post design study.
    Khan OF; Cusano E; Raissouni S; Pabia M; Haeseker J; Bosma N; Ko JJ; Li H; Kumar A; Vickers MM; Tang PA
    BMC Cancer; 2019 Feb; 19(1):150. PubMed ID: 30764801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy was not associated with cognitive decline in older adults with breast and colorectal cancer: findings from a prospective cohort study.
    Shaffer VA; Merkle EC; Fagerlin A; Griggs JJ; Langa KM; Iwashyna TJ
    Med Care; 2012 Oct; 50(10):849-55. PubMed ID: 22683591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between cognitive impairment and guideline adherence for application of chemotherapy in older patients with breast cancer: Results from the prospective multicenter BRENDA II study.
    Leinert E; Schwentner L; Blettner M; Wöckel A; Felberbaum R; Flock F; Kühn T; Denkinger MD; Janni W; Kreienberg R; Singer S;
    Breast J; 2019 May; 25(3):386-392. PubMed ID: 30945393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
    Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
    J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
    Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
    Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological Effects of Chemotherapy: Systematic Review of Longitudinal Studies on Objective Cognitive Impairment in Breast Cancer Patients.
    Kim HJ; Kim JEE; Jung SO; Lee D; Abraham I
    Cancer Nurs; 2023 May-Jun 01; 46(3):E159-E168. PubMed ID: 35324504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-associated cognitive impairments in Korean cancer patients: Risk factors and functional outcome.
    Kim HJ; Barsevick AM; Chan A; Chae JW
    Psychooncology; 2018 Aug; 27(8):1995-2001. PubMed ID: 29744963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Adjuvant Chemotherapy on Cognitive Function of Patients With Early-stage Colorectal Cancer.
    Sales MVC; Suemoto CK; Apolinario D; Serrao V; Andrade CS; Conceição DM; Amaro E; de Melo BAR; Riechelmann RP
    Clin Colorectal Cancer; 2019 Mar; 18(1):19-27. PubMed ID: 30297263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
    Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
    Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal investigation of cognitive deficits in breast cancer patients and their gray matter correlates: impact of education level.
    Perrier J; Viard A; Levy C; Morel N; Allouache D; Noal S; Joly F; Eustache F; Giffard B
    Brain Imaging Behav; 2020 Feb; 14(1):226-241. PubMed ID: 30406352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study.
    Cheung YT; Ng T; Shwe M; Ho HK; Foo KM; Cham MT; Lee JA; Fan G; Tan YP; Yong WS; Madhukumar P; Loo SK; Ang SF; Wong M; Chay WY; Ooi WS; Dent RA; Yap YS; Ng R; Chan A
    Ann Oncol; 2015 Jul; 26(7):1446-51. PubMed ID: 25922060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer].
    Park JH; Bae SH; Jung YS; Jung YM
    J Korean Acad Nurs; 2015 Feb; 45(1):118-28. PubMed ID: 25743740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Acupuncture Therapy for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients.
    Tong T; Pei C; Chen J; Lv Q; Zhang F; Cheng Z
    Med Sci Monit; 2018 May; 24():2919-2927. PubMed ID: 29735975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verbal memory in breast cancer patients treated with chemotherapy with doxorubicin and cyclophosphamide.
    Andryszak P; Wiłkość M; Żurawski B; Izdebski P
    Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28850754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study.
    Fischer B
    Neurocase; 2019; 25(3-4):138-144. PubMed ID: 31237172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer.
    Lange M; Heutte N; Noal S; Rigal O; Kurtz JE; Lévy C; Allouache D; Rieux C; Lefel J; Clarisse B; Leconte A; Veyret C; Barthélémy P; Longato N; Tron L; Castel H; Eustache F; Giffard B; Joly F
    Oncologist; 2019 Jan; 24(1):62-68. PubMed ID: 29934409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.
    Toh YL; Shariq Mujtaba J; Bansal S; Yeo A; Shwe M; Lau AJ; Chan A
    Pharmacotherapy; 2019 May; 39(5):553-563. PubMed ID: 30892712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.